This bill would allow for $622.1 million dollars to be spent by various federal agencies to fight the Zika virus and prevent it from spreading. If enacted, this funding would be available immediately and would remain available for the rest of the 2016 fiscal year (which runs through September).
None of this funding is new, as it is fully offset by $352.1 million in unused money set aside for the Ebola outbreak and another $270 million in unused administrative funds from the Dept. of Health and Human Services (HHS).
The Centers for Disease Control and Prevention (CDC) would get $170 million that would primarily be spent on mosquito control, disease-related research, public education, and Zika preparedness in vulnerable states and territories. Of the total, $50 million would be set aside for health programs for mothers and children in states and territories with Zika outbreaks which would cover prenatal care, delivery and postpartum care, and care for infants with special healthcare needs related to Zika.
$230 million would go to the National Institutes of Health (NIH) for vaccine development to stop the spread of infection and prevent future outbreaks. The Biomedical Advanced Research and Development Authority (BARDA) would get $103 million for research and development related to Zika, including the production and deployment of new rapid tests for diagnosing Zika and vaccines.
The State Department would get $119.1 million for the U.S. Agency for International Development (USAID), of which $100 million would fund Global Health programs aimed at stopping the spread of the virus through mosquito control. The remaining $19.1 million would be used to staff and manage Zika-related programs, coordinate with foreign government, and provide resources for travelers and at-risk U.S. citizens in countries affected by Zika.
For the sake of ensuring oversight of this spending, $2 million would go to the Government Accountability Office (GAO) and inspector generals at HHS and USAID.